The Thoratec ventricular assist device system

Whittaker, S; Glanville, C
July 2000
Perfusion;Jul2000, Vol. 15 Issue 4, p363
Academic Journal
Deals with the use of the Thoratec ventricular cardiac assist device system. Discussion on the prosthetic ventricle; Clinical results; New devices and support products being developed for Thoratec's existing devices as of 2000.


Related Articles

  • Gender a greater focus at cardiovascular meeting.  // Medical Technology & Devices Week;11/12/2007, Vol. 5 Issue 45, p4 

    The article deals with the differences of men and women in terms of responses to treatment for heart diseases, which was discussed at the 2007 sessions of the American Heart Association. A study presented by Soo Hyun Kin of the Cleveland Clinic revealed that therapies in women often focused on...

  • Cardiac sarcoidosis responding to monotherapy with infliximab. Uthman, Imad; Touma, Zahi; Khoury, Maurice // Clinical Rheumatology;Nov2007, Vol. 26 Issue 11, p2001 

    Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions....


    This article studies the evolution of ventricular tachyarrhythmias in myocardial infarction survivors. This study evaluated prospectively the incidence of arrhythmic events, sudden death, sustained ventricular tachycardia, ventricular fibrillation, in the year following myocardial infarction...

  • Wireless heart monitoring system can transmit data globally. Raible, Eric // Cardiology Today;Jun2009, Vol. 12 Issue 6, p21 

    The article reports on a wireless heart monitoring system which is capable of transmitting cardiac health status, available in the U.S.

  • Cytori says business model for Celution as strong as research. McCarty, Mark // Medical Device Daily;10/24/2007, Vol. 11 Issue 204, p1 

    This article reports on the initiation of clinical trials by Cytori to evaluate its stem-cell sorter, the Celution. The medical device company intends to prove that the Celution can provide stem cells that will aid the damaged heart. The first study evaluates the safety and feasibility of...

  • Researchers report progress in treating MI. Alexander, Walter // Drug Topics;10/24/2005, Vol. 149 Issue 20, Special section p9 

    This article focused on the pharmacological treatment of myocardial infarction. Identifies the risks of such therapy and attempt to combine therapies. Interventional cardiologists find that performing a percutaneous coronary intervention on MI patients is much easier when the infarct-related...

  • COMMENTARY: Cardiac resynchronization therapy reduced all-cause death and hospitalization in chronic heart failure. Morillo, Carlos A. // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p60 

    The article presents a commentary on the study, which concluded that Cardiac resynchronization therapy reduced all-cause death and hospitalization in chronic heart failure. Despite major improvements in treating HF, mortality remains high. Newer therapeutic approaches have focused on the...

  • Cappella Medical to Share Data Documenting Benefits of Full Ostial Protection at EuroPCR 2011.  // Biomedical Market Newsletter;5/17/2011, p627 

    The article reports the presentation of the Cappella Inc. at a May 2011 meeting in Paris, France on the role of its coronary sidebranch technology in coronary bifurcation disease. At Europeans Association of Percutaneous Cardiovascular Interventions (EuroPCR) Congress, Cappella will show that...

  • Review: Implantable cardioverter defibrillators reduce sudden cardiac death, all-cause mortality, and cardiac mortality. Newman, David // ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p31 

    Presents a study that analyzed the effectiveness of implantable cardioverter defibrillators in reducing sudden cardiac death, all-cause mortality and cardiac mortality. Data sources; Data extraction; Results; Conclusion; Commentary.

  • Diameter changes of occluded venous coronary artery bypass grafts in electron beam tomography: preliminary findings Enzweiler, Christian N.H.; Wiese, Till H.; Petersein, Jan; Lembcke, Alexander E.; Borges, Adrian C.; Dohmen, Pascal; Hoffmann, Udo; Hamm, Bernd // European Journal of Cardio-Thoracic Surgery;Mar2003, Vol. 23 Issue 3, p347 

    Objective: To differentiate acute from chronic graft occlusions through diameter measurements by means of electron beam tomography (EBT). Methods: Contrast enhanced EBT volume studies were carried out in 37 patients with one or more occluded venous coronary bypass grafts. Seventeen of 37...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics